BCH-320 Assignment
BCH-320 Assignment
BCH-320 Assignment
Assignment 01
Submitted by
Submitted To
Ma’am. Mubeen Tahir
Submitted for
Agriculture Biotechnology (BTH-320)
DEPARTMENT OF BIOCHEMISTRY & BIOTECHNOLOGY
Table of content
Gene expression is the expression of a genes that mean when a gene encoding into a messenger RNA
I I I I I I I I I I I I I I I I I
which will be translate into proteins. Production of a protein from gene code is known as gene
I I I I I I I I I I I I I I I I I
expression. Gene expression vary from human to human and by time and space. Like A human need
I I I I I I I I I I I I I I I I I
more growth hormone in early age while a woman which is older than 50 years need less human
I I I I I I I I I I I I I I I I I I
growth hormone. In the same way some jeans do not Express in childhood while the express puberty.
I I I I I I I I I I I I I I I I I
The enhancers are the short DNA sequence that play a crucial role in the particular genes
I I I I I I I I I I I I I I I
transcription. Enhancer play a role to change the rate of the transcription enhancer are present mostly
I I I I I I I I I I I I I I I I
in the upstream of the Genes. Enhancer's play a very important role that increase the activity of the
I I I I I I I I I I I I I I I I I I
promoter of the gene. As enhancer increases the activity of the promoter therefore they increase the
I I I I I I I I I I I I I I I I
gene expression.
I I
Enhancer are the non-coding DNA sequence that can make interaction with many transcription
I I I I I I I I I I I I
factors to enhance the expression of genes. in the opposite way silencer also non coding DNA
I I I I I I I I I I I I I I I I
Usually, the enhancer work with the TFs ( transcription factors). As first enhancer bind with TF
I I I I I I I I I I I I I I I
followed by the different recruitment such as histone acetyltransferases and chromatin remodelers
I I I I I I I I I I I I
which play role in the increase in the accessibility of the chromatin. The increase accessibility will
I I I I I I I I I I I I I I I I
In this way enhancer play role to activate the target gene and enhance the gene expression as more TFs
I I I I I I I I I I I I I I I I I I
bind to promoter and more mRNA produce and more translation will be occurred and more protein
I I I I I I I I I I I I I I I I
will be produced. To do so, enhancers physically interact with the promoters of their cognate gene
I I I II II II II I I I I I I I I I
and we knew the RNA polymerase II is the enzyme that start transcription and produce mRNA
I I I I I I I I I I I I I I I I
enhancer play great role in the stability of RNA polymerase II on the promoter site so the
I I I I I I I I I I I I I I I I I
Enhancers have the special TFs binding motif which will bind the TFs with promoter region which
I I I I I I I I I I I I I I I
will lead to activation of different TFs and other supportive proteins which lead to the production of
I I I I I I I I I I I I I I I I I
the mRNA which will translate into protein at ribosome. As more protein produce which mean more
I I I I I I I I I I I I I I I I
mRNA were synthesis and which ultimate lead that RNA polymerase II has great binding at the
I I I I I I I I I I I I I I I I
1|Page
Biotechnology is the branch of biology which involves the use of living systems and organisms to I I I I I I I I I I I I I I I
Biotechnology e has a great role to increase the life expectancy of the people. The main areas in which I I I I I I I I I I I I I I I I I I
biotechnology can play a crucial role and may helpful to increase the life expectancy of the people.
I I I I I I I I I I I I I I I I I
Medicine
Biotechnology has a great role in the production of drugs and to cure diseases. So, by making perfect I I I I I I I I I I I I I I I I I
drugs and by using gene therapy methodology life expectancy can be increased.
I I I I I I I I I I I I
Environmental purposes I
we can do bioremediation. As we know now bioremediation is the process in which we can use
I I I I I I I I I I I I I I I I I
microorganisms to remove or detoxify the pollutants. By cleaning the environment and improving
I I I I I I I I I I I I I
the crop yield and removing the heavy metal from water life expectancy will increase.
I I I I I I I I I I I I I I
As biotechnology is a science in which we play with the genes of the different organisms by using
I I I I I I I I I I I I I I I I I
different tools and methods. Recombinant plants and different kinds of recombinant crops have
I I I I I I I I I I I I I
much greater jailed as compared to the normal plants and they also have resistance against insects and
I I I I I I I I I I I I I I I I I
herbicides.
I
One important advantage of biotechnology is that we can produce high quality food and a food which
I I I I I I I I I I I I I I I I
have a longer shelf life. Alwar now genetics can be altered through the recombinant technology e
I I I I I I I I I I I I I I I I
scientists can produce the crops that contain the higher level of certain healthy component. By seeing
I I I I I I I I I I I I I I II I
this factor, we can assume that technology will be able to expand the life expectancy of the people.
I I I I I I I I I I I I I I I I I I
Regenerative medicine I
Regenerative medicine grows very dramatically fast as this have a very important role in the injury.
I I I I I I I I I I I I I I I
Tissue engineering based on different types of bio-materials has been made to speed up the rate of
I I I I I I I I I I I I I I I I I
regenerative medicine. Recently stem cell specially induces pluripotent stem cells (iPS) show the
I I I I I I I I I I I I I
great regenerative medicine quality. Imagine future with regenerative medicine that a person loses
I I I I I I I I I I I I I
his arm or leg and by using the regenerative medicine that person can have his arm or leg once again in
I I I I I I I I I I I I I I I I I I I I I
All these factors and areas show that biotechnology will be able to increase the life expectancy of the
I I I I I I I I I I I I I I I I I
life and future people will live longer life and they have great health facility as compare to today
I I I I I I I I I I I I I I I I I I
people.
I I
2|Page
How can RNA–DNA chimeric molecules be used to introduce targeted
I I I I I I I I I
Chimeric are the oligonucleotides (chimeras) molecules, which have basic part of RNA and DNA
I I I I I I I I I I I I I
bases folded by complementarity like double hairpin conformation, they have role to alter or repair
I I I I I I I I I I I I I I I
single bases in plant and animal genomes. Means that we can use these chimeric molecules to make
I I I I I I I I I I I I I I I I I
target gene alteration in the DNA for our requirement protein or for our required characteristic.
I I I I I I I I I I I I I I II
An uninterrupted DNA sequence may be altering and RNA chimeric will help to make stable
I I I I I I I I I I I I I I
RNA DNA chimeric molecules work as a site directed manipulation of the chromosomal genes this
I I I I I I I I I I I I I I
method worked in the bacteria yeast and mammalian cells. This process is developed for mammalian
I I I I I I I I I I I I I I I
gene therapy which provide a great alternative for gene targeting in plants one of the great examples
I I I I I I I I I I I I I I I I I
In some researchers these RNA DNA chimeric molecules are referred to as Crispr cas9 systems. In
I I I I I I I I I I I I I I I
which they say that that guiding RNA and cash 9 protein will work together and make chimeric
I I I I I I I I I I I I I I I I I
molecule they basically focus on the complex that will be formed between guide RNA a and DNA
I I I I I I I I I I I I I I I I I
that is formed before the cash 9 protein interaction. As guide RNA is the complementary to our target
I I I I I I I I I I I I I I I I I I
region so cas9 protein will bind to guide RNA and produce cut on the DNA and after that by Homer
I I I I I I I I I I I I I I I I I I I I
logos are nonhomologous end joining we can substitute add or delete a gene or a nucleotide from that
I I I I I I I I I I I I I I I I I I
region. in this way we can do target gene editing in plants by using RNA DNA chimeric molecules.
I I I I I I I I I I I I I I I I I I
3|Page
Reference
I. Luo Z, Macris MA, Faruqi AF, Glazer PM . High-frequency intrachromosomal gene conversion
induced by triplex-forming oligonucleotides microinjected into mouse cells. Proc Natl Acad Sci
USA 2000; 97: 9003–9008
II. Culver KW et al. Correction of chromosomal point mutations in human cells with bifunctional
oligonucleotides. Nat Biotechnol 1999; 17: 989–993.
III. Vasquez KM, Narayanan L, Glazer PM . Specific mutations induced by triplex-forming
oligonucleotides in mice. Science 2000; 290: 530–533.
4|Page